Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

Safe and Successful Treatment of Acute Cellular Rejection of an Intestine and Abdominal Wall Transplant With Vedolizumab.

Trentadue G, Kats-Ugurlu G, Blokzijl T, Diercks GF, Haveman JW, Faber KN, Dijkstra G.

Transplant Direct. 2020 Jan 17;6(2):e527. doi: 10.1097/TXD.0000000000000973. eCollection 2020 Feb.

2.

Riboflavin supplementation in patients with Crohn's disease (RISE-UP study).

von Martels JZH, Bourgonje AR, Klaassen MAY, Alkhalifah HAA, Sadaghian Sadabad M, Vich Vila A, Gacesa R, Gabriëls RY, Steinert RE, Jansen BH, Bulthuis MLC, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, de Vos P, van Goor H, Faber KN, Harmsen HJM, Dijkstra G.

J Crohns Colitis. 2019 Dec 24. pii: jjz208. doi: 10.1093/ecco-jcc/jjz208. [Epub ahead of print]

PMID:
31873717
3.

A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease.

Bourgonje AR, von Martels JZH, Gabriëls RY, Blokzijl T, Buist-Homan M, Heegsma J, Jansen BH, van Dullemen HM, Festen EAM, Ter Steege RWF, Visschedijk MC, Weersma RK, de Vos P, Faber KN, Dijkstra G.

Front Med (Lausanne). 2019 Nov 5;6:251. doi: 10.3389/fmed.2019.00251. eCollection 2019.

4.

Senescent Stem and Transient Amplifying Cells in Crohn's Disease Intestine.

Wang X, Bootsma H, Kroese F, Dijkstra G, Pringle S.

Inflamm Bowel Dis. 2020 Jan 6;26(2):e8-e9. doi: 10.1093/ibd/izz295. No abstract available.

5.

Nutritional Assessment in Inflammatory Bowel Disease (IBD)-Development of the Groningen IBD Nutritional Questionnaires (GINQ).

Peters V, Alizadeh BZ, de Vries JH, Dijkstra G, Campmans-Kuijpers MJ.

Nutrients. 2019 Nov 12;11(11). pii: E2739. doi: 10.3390/nu11112739.

6.

Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab.

Biemans VBC, van der Woude CJ, Dijkstra G, van der Meulen-de Jong AE, Oldenburg B, de Boer NK, Löwenberg M, Srivastava N, Bodelier AGL, West RL, Jansen JM, de Vries AC, Haans JJL, de Jong DJ, Pierik MJ, Hoentjen F.

Clin Pharmacol Ther. 2019 Nov 2. doi: 10.1002/cpt.1712. [Epub ahead of print]

PMID:
31677154
7.

No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis.

Lie MRKL, Kreijne JE, Dijkstra G, Löwenberg M, van Assche G, West RL, van Noord D, van der Meulen-de Jong AE, Oldenburg B, Zaal RJ, Hansen BE, de Vries AC, Janneke van der Woude C; Dutch Initiative on Crohn and Colitis.

Clin Gastroenterol Hepatol. 2019 Oct 11. pii: S1542-3565(19)31100-0. doi: 10.1016/j.cgh.2019.09.049. [Epub ahead of print]

8.

Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease.

Bourgonje AR, Gabriëls RY, de Borst MH, Bulthuis MLC, Faber KN, van Goor H, Dijkstra G.

Antioxidants (Basel). 2019 Sep 1;8(9). pii: E351. doi: 10.3390/antiox8090351.

9.

Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process.

Gareb B, Posthumus S, Beugeling M, Koopmans P, Touw DJ, Dijkstra G, Kosterink JGW, Frijlink HW.

Pharmaceutics. 2019 Aug 23;11(9). pii: E428. doi: 10.3390/pharmaceutics11090428.

10.

Goals of older hospitalised patients: a qualitative descriptive study.

van der Kluit MJ, Dijkstra GJ, de Rooij SE.

BMJ Open. 2019 Aug 5;9(8):e029993. doi: 10.1136/bmjopen-2019-029993.

11.

Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment.

Kreijne JE, de Veer RC, de Boer NK, Dijkstra G, West R, Moorsel SAW, de Jong DJ, van der Woude CJ, de Vries AC; of the Dutch Initiative on Crohn, Colitis (ICC).

Aliment Pharmacol Ther. 2019 Aug;50(4):407-415. doi: 10.1111/apt.15402.

PMID:
31359480
12.

Corrigendum: Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.

Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA.

Front Immunol. 2019 Jun 28;10:1486. doi: 10.3389/fimmu.2019.01486. eCollection 2019.

13.

The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis.

Raselli T, Wyss A, Gonzalez Alvarado MN, Weder B, Mamie C, Spalinger MR, Van Haaften WT, Dijkstra G, Sailer AW, Imenez Silva PH, Wagner CA, Tosevski V, Leibl S, Scharl M, Rogler G, Hausmann M, Misselwitz B.

J Crohns Colitis. 2019 Sep 19;13(9):1186-1200. doi: 10.1093/ecco-jcc/jjz039.

14.

Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study.

Biemans VBC, van der Meulen-de Jong AE, van der Woude CJ, Löwenberg M, Dijkstra G, Oldenburg B, de Boer NKH, van der Marel S, Bodelier AGL, Jansen JM, Haans JJL, Theeuwen R, de Jong D, Pierik MJ, Hoentjen F.

J Crohns Colitis. 2020 Jan 1;14(1):33-45. doi: 10.1093/ecco-jcc/jjz119.

PMID:
31219157
15.

Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.

Barnhoorn MC, Wasser MNJM, Roelofs H, Maljaars PWJ, Molendijk I, Bonsing BA, Oosten LEM, Dijkstra G, van der Woude CJ, Roelen DL, Zwaginga JJ, Verspaget HW, Fibbe WE, Hommes DW, Peeters KCMJ, van der Meulen-de Jong AE.

J Crohns Colitis. 2020 Jan 1;14(1):64-70. doi: 10.1093/ecco-jcc/jjz116.

16.

Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease: A Nationwide Cohort Study.

Beelen EMJ, van der Woude CJ, Pierik MJ, Hoentjen F, de Boer NK, Oldenburg B, van der Meulen AE, Ponsioen CIJ, Dijkstra G, Bruggink AH, Erler NS, Schouten WR, de Vries AC; Dutch Initiative on Crohnʼs and Colitis (ICC).

Ann Surg. 2019 Jun 10. doi: 10.1097/SLA.0000000000003395. [Epub ahead of print]

PMID:
31188225
17.

Effects of Dementia Care Mapping on job satisfaction and caring skills of staff caring for older people with intellectual disabilities: A quasi-experimental study.

Schaap FD, Finnema EJ, Stewart RE, Dijkstra GJ, Reijneveld SA.

J Appl Res Intellect Disabil. 2019 Sep;32(5):1228-1240. doi: 10.1111/jar.12615. Epub 2019 May 13.

18.

Crohn's Disease in Clinical Remission Is Marked by Systemic Oxidative Stress.

Bourgonje AR, von Martels JZH, Bulthuis MLC, van Londen M, Faber KN, Dijkstra G, van Goor H.

Front Physiol. 2019 Apr 26;10:499. doi: 10.3389/fphys.2019.00499. eCollection 2019.

19.

Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.

Klaassen MAY, Imhann F, Collij V, Fu J, Wijmenga C, Zhernakova A, Dijkstra G, Festen EAM, Gacesa R, Vich Vila A, Weersma RK.

J Crohns Colitis. 2019 Oct 28;13(11):1439-1449. doi: 10.1093/ecco-jcc/jjz077.

PMID:
31066440
20.

Correction to: The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1.

Imhann F, Van der Velde KJ, Barbieri R, Alberts R, Voskuil MD, Vila AV, Collij V, Spekhorst LM, Van der Sloot KWJ, Peters V, Van Dullemen HM, Visschedijk MC, Festen EAM, Swertz MA, Dijkstra G, Weersma RK.

BMC Gastroenterol. 2019 Mar 27;19(1):44. doi: 10.1186/s12876-019-0938-8.

21.

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.

Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA.

Front Immunol. 2019 Mar 11;10:277. doi: 10.3389/fimmu.2019.00277. eCollection 2019. Review. Erratum in: Front Immunol. 2019 Jun 28;10:1486.

22.

Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.

Simsek M, Lissenberg-Witte BI, van Riswijk MLM, Verschuren S, Hoentjen F, Oldenburg B, Ponsioen CY, van der Woude CJ, van der Meulen AE, Pierik M, Dijkstra G, de Boer NKH; Parelsnoer Institute (PSI), the Dutch Initiative on Crohn's and Colitis (ICC).

Aliment Pharmacol Ther. 2019 May;49(10):1293-1300. doi: 10.1111/apt.15229. Epub 2019 Mar 25.

23.

Effects of Dementia Care Mapping on well-being and quality of life of older people with intellectual disability: A quasi-experimental study.

Schaap FD, Dijkstra GJ, Stewart RE, Finnema EJ, Reijneveld SA.

J Appl Res Intellect Disabil. 2019 Jul;32(4):849-860. doi: 10.1111/jar.12576. Epub 2019 Mar 13.

24.

Assessing intestinal permeability in Crohn's disease patients using orally administered 52Cr-EDTA.

von Martels JZH, Bourgonje AR, Harmsen HJM, Faber KN, Dijkstra G.

PLoS One. 2019 Feb 7;14(2):e0211973. doi: 10.1371/journal.pone.0211973. eCollection 2019.

25.

SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects.

Collij V, Imhann F, Vich Vila A, Fu J, Dijkstra G, Festen EAM, Voskuil MD, Daly MJ, Xavier RJ, Wijmenga C, Zhernakova A, Weersma RK.

PLoS One. 2019 Jan 31;14(1):e0211328. doi: 10.1371/journal.pone.0211328. eCollection 2019.

26.

The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1.

Imhann F, Van der Velde KJ, Barbieri R, Alberts R, Voskuil MD, Vich Vila A, Collij V, Spekhorst LM, Van der Sloot KWJ, Peters V, Van Dullemen HM, Visschedijk MC, Festen EAM, Swertz MA, Dijkstra G, Weersma RK.

BMC Gastroenterol. 2019 Jan 8;19(1):5. doi: 10.1186/s12876-018-0917-5. Erratum in: BMC Gastroenterol. 2019 Mar 27;19(1):44.

27.

The decision-making process for unplanned admission to hospital unveiled in hospitalised older adults: a qualitative study.

van der Kluit MJ, Dijkstra GJ, de Rooij SE.

BMC Geriatr. 2018 Dec 22;18(1):318. doi: 10.1186/s12877-018-1013-y.

28.

Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.

Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, Dekens J, Peters V, Voskuil MD, Visschedijk MC, van Dullemen HM, Keszthelyi D, Swertz MA, Franke L, Alberts R, Festen EAM, Dijkstra G, Masclee AAM, Hofker MH, Xavier RJ, Alm EJ, Fu J, Wijmenga C, Jonkers DMAE, Zhernakova A, Weersma RK.

Sci Transl Med. 2018 Dec 19;10(472). pii: eaap8914. doi: 10.1126/scitranslmed.aap8914.

PMID:
30567928
29.

Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn's Fistulas: A Case Report.

Barnhoorn MC, Van Halteren AGS, Van Pel M, Molendijk I, Struijk AC, Jansen PM, Verspaget HW, Dijkstra G, Oosten LEM, Van der Meulen-de Jong AE.

J Crohns Colitis. 2019 May 27;13(6):807-811. doi: 10.1093/ecco-jcc/jjy220.

PMID:
30561580
30.

Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-α biologicals and an Infliximab-biosimilar.

Buurman DJ, Blokzijl T, Festen EAM, Pham BT, Faber KN, Brouwer E, Dijkstra G.

PLoS One. 2018 Dec 11;13(12):e0208922. doi: 10.1371/journal.pone.0208922. eCollection 2018.

31.

Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice.

Gareb B, Dijkstra G, Kosterink JGW, Frijlink HW.

Int J Pharm. 2019 Jan 10;554:366-375. doi: 10.1016/j.ijpharm.2018.11.019. Epub 2018 Nov 8.

PMID:
30414898
32.

Single-Cell RNA Sequencing of Blood and Ileal T Cells From Patients With Crohn's Disease Reveals Tissue-Specific Characteristics and Drug Targets.

Uniken Venema WT, Voskuil MD, Vila AV, van der Vries G, Jansen BH, Jabri B, Faber KN, Dijkstra G, Xavier RJ, Wijmenga C, Graham DB, Weersma RK, Festen EA.

Gastroenterology. 2019 Feb;156(3):812-815.e22. doi: 10.1053/j.gastro.2018.10.046. Epub 2018 Nov 2. No abstract available.

33.

Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to Fibrogenesis.

Hutter S, van Haaften WT, Hünerwadel A, Baebler K, Herfarth N, Raselli T, Mamie C, Misselwitz B, Rogler G, Weder B, Dijkstra G, Meier CF, de Vallière C, Weber A, Imenez Silva PH, Wagner CA, Frey-Wagner I, Ruiz PA, Hausmann M.

J Crohns Colitis. 2018 Nov 15;12(11):1348-1358. doi: 10.1093/ecco-jcc/jjy118.

34.

Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ).

van der Sloot KWJ, Weersma RK, Dijkstra G, Alizadeh BZ.

J Gastroenterol. 2019 Mar;54(3):238-248. doi: 10.1007/s00535-018-1501-z. Epub 2018 Aug 14.

35.

Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients.

Simsek M, Meijer B, Ramsoekh D, Bouma G, van der Wouden EJ, den Hartog B, de Vries AC, Hoentjen F, Dijkstra G, de Boer SY, Jansen JM, van der Meulen AE, Beukers R, Brink MA, Steinhauser T, Oldenburg B, Gilissen LP, Naber TH, Verhagen MA, de Boer NKH, Mulder CJJ; Dutch Initiative on Crohn and Colitis (ICC).

Clin Gastroenterol Hepatol. 2019 Feb;17(3):568-570. doi: 10.1016/j.cgh.2018.05.009. Epub 2018 Jun 1.

PMID:
29775790
36.

Dementia care mapping to support staff in the care of people with intellectual disability and dementia: a feasibility study.

Schaap FD, Fokkens AS, Dijkstra GJ, Reijneveld SA, Finnema EJ.

J Appl Res Intellect Disabil. 2018 Nov;31(6):1071-1082. doi: 10.1111/jar.12464. Epub 2018 Apr 24.

PMID:
29691956
37.

Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies.

Severs M, Spekhorst LM, Mangen MJ, Dijkstra G, Löwenberg M, Hoentjen F, van der Meulen-de Jong AE, Pierik M, Ponsioen CY, Bouma G, van der Woude JC, van der Valk ME, Romberg-Camps MJL, Clemens CHM, van de Meeberg P, Mahmmod N, Jansen J, Jharap B, Weersma RK, Oldenburg B, Festen EAM, Fidder HH.

Inflamm Bowel Dis. 2018 May 18;24(6):1298-1306. doi: 10.1093/ibd/izy004.

PMID:
29688413
38.

Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness.

Meijer B, Mulder CJJ, Bouma G, Ponsioen CY, van der Woude CJ, van der Meulen AE, Wintjens DSJ, Dijkstra G, Hoentjen F, Oldenburg B, van Bodegraven AA, de Boer NKH; Dutch Initiative on Crohn and Colitis (ICC) and Parelsnoer Institute.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1558-1565. doi: 10.1093/ibd/izy047.

PMID:
29668998
39.

A case of spontaneous urinary bladder rupture secondary to urinary retention due to an urethral stricture.

Palthe S, Dijkstra GA, Steffens MG.

Urol Case Rep. 2018 Jan 11;17:85-87. doi: 10.1016/j.eucr.2018.01.009. eCollection 2018 Mar.

40.

Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines.

Bourgonje AR, von Martels JZH, de Vos P, Faber KN, Dijkstra G.

PLoS One. 2018 Feb 21;13(2):e0193202. doi: 10.1371/journal.pone.0193202. eCollection 2018.

41.

Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease.

Visschedijk MC, Spekhorst LM, Cheng SC, van Loo ES, Jansen BHD, Blokzijl T, Kil H, de Jong DJ, Pierik M, Maljaars JPWJ, van der Woude CJ, van Bodegraven AA, Oldenburg B, Löwenberg M, Nieuwenhuijs VB, Imhann F, van Sommeren S, Alberts R, Xavier RJ, Dijkstra G, Nico Faber K, Aldaz CM, Weersma RK, Festen EAM.

J Crohns Colitis. 2018 Apr 27;12(5):582-588. doi: 10.1093/ecco-jcc/jjy001.

PMID:
29361163
42.

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease.

Spekhorst LM, Oldenburg B, van Bodegraven AA, de Jong DJ, Imhann F, van der Meulen-de Jong AE, Pierik MJ, van der Woude JC, Dijkstra G, D'Haens G, Löwenberg M, Weersma RK, Festen EAM; Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis.

World J Gastroenterol. 2017 Dec 14;23(46):8182-8192. doi: 10.3748/wjg.v23.i46.8182.

43.

The first use of dementia care mapping in the care for older people with intellectual disability: a process analysis according to the RE-AIM framework.

Schaap FD, Dijkstra GJ, Finnema EJ, Reijneveld SA.

Aging Ment Health. 2018 Jul;22(7):912-919. doi: 10.1080/13607863.2017.1401582. Epub 2017 Nov 24.

PMID:
29171286
44.

Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease.

Spekhorst LM, Imhann F, Festen EAM, van Bodegraven AA, de Boer NKH, Bouma G, Fidder HH, d'Haens G, Hoentjen F, Hommes DW, de Jong DJ, Löwenberg M, Maljaars PWJ, van der Meulen-de Jong AE, Oldenburg B, Pierik MJ, Ponsioen CY, Stokkers PC, Verspaget HW, Visschedijk MC, van der Woude CJ, Dijkstra G, Weersma RK; Parelsnoer Institute (PSI) and the Dutch Initiative on Crohn and Colitis (ICC).

BMJ Open. 2017 Nov 8;7(11):e016695. doi: 10.1136/bmjopen-2017-016695.

45.

Aid and good governance: Examining aggregate unintended effects of aid.

Dijkstra G.

Eval Program Plann. 2018 Jun;68:225-232. doi: 10.1016/j.evalprogplan.2017.09.004. Epub 2017 Sep 18.

46.

The Impact of Ethnicity and Country of Birth on Inflammatory Bowel Disease Phenotype: a Prospective Cohort Study.

Spekhorst LM, Severs M, de Boer NKH, Festen EAM, Fidder HH, Hoentjen F, Imhann F, de Jong DJ, van der Meulen-de Jong AE, Pierik MJ, van der Woude CJ, Dijkstra G, Ponsioen CY, Löwenberg M, Oldenburg B, Weersma RK; Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis.

J Crohns Colitis. 2017 Dec 4;11(12):1463-1470. doi: 10.1093/ecco-jcc/jjx098.

PMID:
28981621
47.

Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units.

Meijer B, Simsek M, Blokzijl H, de Man RA, Coenraad MJ, Dijkstra G, van Nieuwkerk CM, Mulder CJ, de Boer NK.

United European Gastroenterol J. 2017 Aug;5(5):658-667. doi: 10.1177/2050640616680550. Epub 2016 Nov 16.

48.

Inflammatory Bowel Diseases: Review of Known Environmental Protective and Risk Factors Involved.

van der Sloot KWJ, Amini M, Peters V, Dijkstra G, Alizadeh BZ.

Inflamm Bowel Dis. 2017 Sep;23(9):1499-1509. doi: 10.1097/MIB.0000000000001217. Review.

PMID:
28777099
49.

Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial.

de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, Maljaars JP, Cilissen M, van Bodegraven AA, Mahmmod N, Markus T, Hameeteman WM, Dijkstra G, Masclee AA, Boonen A, Winkens B, van Tubergen A, Jonkers DM, Pierik MJ.

Lancet. 2017 Sep 2;390(10098):959-968. doi: 10.1016/S0140-6736(17)31327-2. Epub 2017 Jul 14.

PMID:
28716313
50.

Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease.

Severs M, Mangen MJ, Fidder HH, van der Valk ME, van der Have M, van Bodegraven AA, Clemens CHM, Dijkstra G, Jansen JM, de Jong DJ, Mahmmod N, van de Meeberg PC, van der Meulen-de Jong AE, Pierik M, Ponsioen CY, Romberg-Camps MJL, Siersema PD, Jharap B, van der Woude JC, Zuithoff NPA, Oldenburg B.

Inflamm Bowel Dis. 2017 Sep;23(9):1568-1576. doi: 10.1097/MIB.0000000000001201.

PMID:
28700534

Supplemental Content

Loading ...
Support Center